Global Histoplasmosis Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

November 2018 | 121 pages | ID: G30DE141B51EN
GlobalInfoResearch

Abstracts

Histoplasmosis is an infection that occurs from breathing spores of a fungus called Histoplasma capsulatum. Histoplasmosis is a fungal infection that occurs throughout the world. Histoplasma fungus grows as a mold in the soil. The soil that contains the droppings of bat or birds usually contains large amount of this fungus. The people with weakened immune system are usually more prone and increases the risk of being affected or reactivated with histoplasmosis. Usually people very young, old people and people affected with cancer, AIDS or organ transplant have severe symptoms. The people with chronic lung disease such as bronchiectasis or emphysema have high risk of severe pain. The common symptoms of histoplasmosis is fever, chills, cough, chest pain, red skin bumps, mouth sores etc. In some patients suffering from histoplasmosis may spread throughout the body and cause irritation and swelling in response to infection.

Scope of the Report:

Certain symptoms also includes chest pain from swelling in lining of heart, neck stiffness etc. The disease is usually diagnosed with biopsy of lungs, skin, liver or bone marrow. Certain blood and urine test also help in detection histoplasmosis proteins or antibodies of the fungus in body. In some cases doctors also perform Chest CT scan, Chest X-ray, Bronchoscopy etc.
The global Histoplasmosis Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Histoplasmosis Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Histoplasmosis Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Histoplasmosis Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers

• Bristol Myers Squibb
• Sigma tau pharmaceuticals Inc.
• Three rivers pharmaceuticals
• Astellas pharma US Inc.
• Abbott laboratories
• Abraxis pharmaceutical products
• Teva parenteral medicines Inc.
• X gen pharmaceuticals Inc.

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Amphotericin B
• Itraconazole
• Ketoconazole
• Other

Market Segment by Applications, can be divided into

• Hospitals Pharmacies
• Private clinics
• Drug stores and retail pharmacy
• E-commerce

Contents

1 HISTOPLASMOSIS TREATMENT MARKET OVERVIEW

1.1 Product Overview and Scope of Histoplasmosis Treatment
1.2 Classification of Histoplasmosis Treatment by Types
  1.2.1 Global Histoplasmosis Treatment Revenue Comparison by Types (2017-2023)
  1.2.2 Global Histoplasmosis Treatment Revenue Market Share by Types in 2017
  1.2.3 Amphotericin B
  1.2.4 Itraconazole
  1.2.5 Ketoconazole
  1.2.6 Other
1.3 Global Histoplasmosis Treatment Market by Application
  1.3.1 Global Histoplasmosis Treatment Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals Pharmacies
  1.3.3 Private clinics
  1.3.4 Drug stores and retail pharmacy
  1.3.5 E-commerce
1.4 Global Histoplasmosis Treatment Market by Regions
  1.4.1 Global Histoplasmosis Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Histoplasmosis Treatment Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Histoplasmosis Treatment Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Histoplasmosis Treatment Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Histoplasmosis Treatment Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Histoplasmosis Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Histoplasmosis Treatment (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Bristol Myers Squibb
  2.1.1 Business Overview
  2.1.2 Histoplasmosis Treatment Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Bristol Myers Squibb Histoplasmosis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Sigma tau pharmaceuticals Inc.
  2.2.1 Business Overview
  2.2.2 Histoplasmosis Treatment Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Sigma tau pharmaceuticals Inc. Histoplasmosis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Three rivers pharmaceuticals
  2.3.1 Business Overview
  2.3.2 Histoplasmosis Treatment Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Three rivers pharmaceuticals Histoplasmosis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Astellas pharma US Inc.
  2.4.1 Business Overview
  2.4.2 Histoplasmosis Treatment Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Astellas pharma US Inc. Histoplasmosis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Abbott laboratories
  2.5.1 Business Overview
  2.5.2 Histoplasmosis Treatment Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Abbott laboratories Histoplasmosis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 Abraxis pharmaceutical products
  2.6.1 Business Overview
  2.6.2 Histoplasmosis Treatment Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Abraxis pharmaceutical products Histoplasmosis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 Teva parenteral medicines Inc.
  2.7.1 Business Overview
  2.7.2 Histoplasmosis Treatment Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Teva parenteral medicines Inc. Histoplasmosis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.8 X gen pharmaceuticals Inc.
  2.8.1 Business Overview
  2.8.2 Histoplasmosis Treatment Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 X gen pharmaceuticals Inc. Histoplasmosis Treatment Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL HISTOPLASMOSIS TREATMENT MARKET COMPETITION, BY PLAYERS

3.1 Global Histoplasmosis Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Histoplasmosis Treatment Players Market Share
  3.2.2 Top 10 Histoplasmosis Treatment Players Market Share
3.3 Market Competition Trend

4 GLOBAL HISTOPLASMOSIS TREATMENT MARKET SIZE BY REGIONS

4.1 Global Histoplasmosis Treatment Revenue and Market Share by Regions
4.2 North America Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA HISTOPLASMOSIS TREATMENT REVENUE BY COUNTRIES

5.1 North America Histoplasmosis Treatment Revenue by Countries (2013-2018)
5.2 USA Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)

6 EUROPE HISTOPLASMOSIS TREATMENT REVENUE BY COUNTRIES

6.1 Europe Histoplasmosis Treatment Revenue by Countries (2013-2018)
6.2 Germany Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
6.4 France Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC HISTOPLASMOSIS TREATMENT REVENUE BY COUNTRIES

7.1 Asia-Pacific Histoplasmosis Treatment Revenue by Countries (2013-2018)
7.2 China Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
7.5 India Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA HISTOPLASMOSIS TREATMENT REVENUE BY COUNTRIES

8.1 South America Histoplasmosis Treatment Revenue by Countries (2013-2018)
8.2 Brazil Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE HISTOPLASMOSIS TREATMENT BY COUNTRIES

9.1 Middle East and Africa Histoplasmosis Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)

10 GLOBAL HISTOPLASMOSIS TREATMENT MARKET SEGMENT BY TYPE

10.1 Global Histoplasmosis Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Histoplasmosis Treatment Market Forecast by Type (2018-2023)
10.3 Amphotericin B Revenue Growth Rate (2013-2023)
10.4 Itraconazole Revenue Growth Rate (2013-2023)
10.5 Ketoconazole Revenue Growth Rate (2013-2023)
10.6 Other Revenue Growth Rate (2013-2023)

11 GLOBAL HISTOPLASMOSIS TREATMENT MARKET SEGMENT BY APPLICATION

11.1 Global Histoplasmosis Treatment Revenue Market Share by Application (2013-2018)
11.2 Histoplasmosis Treatment Market Forecast by Application (2018-2023)
11.3 Hospitals Pharmacies Revenue Growth (2013-2018)
11.4 Private clinics Revenue Growth (2013-2018)
11.5 Drug stores and retail pharmacy Revenue Growth (2013-2018)
11.6 E-commerce Revenue Growth (2013-2018)

12 GLOBAL HISTOPLASMOSIS TREATMENT MARKET SIZE FORECAST (2018-2023)

12.1 Global Histoplasmosis Treatment Market Size Forecast (2018-2023)
12.2 Global Histoplasmosis Treatment Market Forecast by Regions (2018-2023)
12.3 North America Histoplasmosis Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Histoplasmosis Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Histoplasmosis Treatment Revenue Market Forecast (2018-2023)
12.6 South America Histoplasmosis Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Histoplasmosis Treatment Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Histoplasmosis Treatment Picture
Table Product Specifications of Histoplasmosis Treatment
Table Global Histoplasmosis Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Histoplasmosis Treatment Revenue Market Share by Types in 2017
Figure Amphotericin B Picture
Figure Itraconazole Picture
Figure Ketoconazole Picture
Figure Other Picture
Table Global Histoplasmosis Treatment Revenue (Million USD) by Application (2013-2023)
Figure Histoplasmosis Treatment Revenue Market Share by Applications in 2017
Figure Hospitals Pharmacies Picture
Figure Private clinics Picture
Figure Drug stores and retail pharmacy Picture
Figure E-commerce Picture
Table Global Market Histoplasmosis Treatment Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Histoplasmosis Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Histoplasmosis Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Histoplasmosis Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Histoplasmosis Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Histoplasmosis Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Histoplasmosis Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Table Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol Myers Squibb Histoplasmosis Treatment Type and Applications
Table Bristol Myers Squibb Histoplasmosis Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Sigma tau pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table Sigma tau pharmaceuticals Inc. Histoplasmosis Treatment Type and Applications
Table Sigma tau pharmaceuticals Inc. Histoplasmosis Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Three rivers pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Three rivers pharmaceuticals Histoplasmosis Treatment Type and Applications
Table Three rivers pharmaceuticals Histoplasmosis Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Astellas pharma US Inc. Basic Information, Manufacturing Base and Competitors
Table Astellas pharma US Inc. Histoplasmosis Treatment Type and Applications
Table Astellas pharma US Inc. Histoplasmosis Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Abbott laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott laboratories Histoplasmosis Treatment Type and Applications
Table Abbott laboratories Histoplasmosis Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Abraxis pharmaceutical products Basic Information, Manufacturing Base and Competitors
Table Abraxis pharmaceutical products Histoplasmosis Treatment Type and Applications
Table Abraxis pharmaceutical products Histoplasmosis Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Teva parenteral medicines Inc. Basic Information, Manufacturing Base and Competitors
Table Teva parenteral medicines Inc. Histoplasmosis Treatment Type and Applications
Table Teva parenteral medicines Inc. Histoplasmosis Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table X gen pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table X gen pharmaceuticals Inc. Histoplasmosis Treatment Type and Applications
Table X gen pharmaceuticals Inc. Histoplasmosis Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Global Histoplasmosis Treatment Revenue (Million USD) by Players (2013-2018)
Table Global Histoplasmosis Treatment Revenue Share by Players (2013-2018)
Figure Global Histoplasmosis Treatment Revenue Share by Players in 2016
Figure Global Histoplasmosis Treatment Revenue Share by Players in 2017
Figure Global Top 5 Players Histoplasmosis Treatment Revenue Market Share in 2017
Figure Global Top 10 Players Histoplasmosis Treatment Revenue Market Share in 2017
Figure Global Histoplasmosis Treatment Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Histoplasmosis Treatment Revenue (Million USD) by Regions (2013-2018)
Table Global Histoplasmosis Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Histoplasmosis Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Histoplasmosis Treatment Revenue Market Share by Regions in 2017
Figure North America Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
Figure Europe Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
Figure South America Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
Table North America Histoplasmosis Treatment Revenue by Countries (2013-2018)
Table North America Histoplasmosis Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Histoplasmosis Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Histoplasmosis Treatment Revenue Market Share by Countries in 2017
Figure USA Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
Figure Canada Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
Figure Mexico Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
Table Europe Histoplasmosis Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Europe Histoplasmosis Treatment Revenue Market Share by Countries (2013-2018)
Figure Europe Histoplasmosis Treatment Revenue Market Share by Countries in 2017
Figure Germany Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
Figure UK Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
Figure France Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
Figure Russia Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
Figure Italy Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Histoplasmosis Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Histoplasmosis Treatment Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Histoplasmosis Treatment Revenue Market Share by Countries in 2017
Figure China Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
Figure Japan Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
Figure Korea Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
Figure India Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
Table South America Histoplasmosis Treatment Revenue by Countries (2013-2018)
Table South America Histoplasmosis Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Histoplasmosis Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Histoplasmosis Treatment Revenue Market Share by Countries in 2017
Figure Brazil Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
Figure Argentina Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
Figure Colombia Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Histoplasmosis Treatment Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Histoplasmosis Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Histoplasmosis Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Histoplasmosis Treatment Revenue Market Share by Countries in 2017
Figure Saudi Arabia Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
Figure UAE Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
Figure Egypt Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
Figure Nigeria Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
Figure South Africa Histoplasmosis Treatment Revenue and Growth Rate (2013-2018)
Table Global Histoplasmosis Treatment Revenue (Million USD) by Type (2013-2018)
Table Global Histoplasmosis Treatment Revenue Share by Type (2013-2018)
Figure Global Histoplasmosis Treatment Revenue Share by Type (2013-2018)
Figure Global Histoplasmosis Treatment Revenue Share by Type in 2017
Table Global Histoplasmosis Treatment Revenue Forecast by Type (2018-2023)
Figure Global Histoplasmosis Treatment Market Share Forecast by Type (2018-2023)
Figure Global Amphotericin B Revenue Growth Rate (2013-2018)
Figure Global Itraconazole Revenue Growth Rate (2013-2018)
Figure Global Ketoconazole Revenue Growth Rate (2013-2018)
Figure Global Other Revenue Growth Rate (2013-2018)
Table Global Histoplasmosis Treatment Revenue by Application (2013-2018)
Table Global Histoplasmosis Treatment Revenue Share by Application (2013-2018)
Figure Global Histoplasmosis Treatment Revenue Share by Application (2013-2018)
Figure Global Histoplasmosis Treatment Revenue Share by Application in 2017
Table Global Histoplasmosis Treatment Revenue Forecast by Application (2018-2023)
Figure Global Histoplasmosis Treatment Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Private clinics Revenue Growth Rate (2013-2018)
Figure Global Drug stores and retail pharmacy Revenue Growth Rate (2013-2018)
Figure Global E-commerce Revenue Growth Rate (2013-2018)
Figure Global Histoplasmosis Treatment Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Histoplasmosis Treatment Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Histoplasmosis Treatment Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Histoplasmosis Treatment Revenue Market Forecast (2018-2023)
Figure Europe Histoplasmosis Treatment Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Histoplasmosis Treatment Revenue Market Forecast (2018-2023)
Figure South America Histoplasmosis Treatment Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Histoplasmosis Treatment Revenue Market Forecast (2018-2023)